ARTEMIS Precision Targeting

Precision Targeting

Eliminates prostate deformation for high accuracy of targeted biopsy

  • Targeted MR/Ultrasound Biopsy
  • 3D Semi Robotic Navigation for Prospective Targeting
  • Patient Motion Compensation
  • Custom Template Biopsy Plans
  • 3D Needle Visualization & Pathology Recording
  • Compatible with all U/S systems
  • Easy Calibration
  • Targeted mpUltrasound Bx
  • Electromechanical Probe Stabilization
  • Detailed Reporting including Previous Biopsy Cores


Precisely target suspected lesions in a repeatable manner
Scan Research
Scan Research
Scan Research
Scan Research
Scan Research

BENEFITS:

Clinical

Avoid freehand biopsy errors

Avoid freehand biopsy errors

Early detection of malignant tumors

Easy guidance to target anterior lesions

Active surveillance & focal therapy

Reduce repeat biopsy sessions

Operational

Quick set-up & intuitive workflow

No sensor-based needle supplies

No specialized room

PACS, cloud & network connectivity

Compatible with all MRI and U/S systems

Seamless radiology-urology integration

Financial

Reduce unnecessary biopsy costs

Reduce unnecessary supply costs

Cost benefits of early detection of PCa

Increased patient satisfaction & retention

Clinical PCa Detection Rate

Conventional U/S

Blind Poke & Hope Procedure

Detection Rate: 27-40%

False Negative Rate ~47%

38% Repeat Biopsy within 5 Years

Often Anterior Lesions Missed

Reduce unnecessary biopsy costs

 

mpMRI

Combine Anatomical & Functional Imaging Comparison of 3 Protocols in 83 Patients

Protocol Sensitivity Specificity Accuracy AUC
T2W 73% 54% 64% 0.711
T2W + DWI 84% 85% 84% 0.905
T2W + DWI + DCE 95% 74% 86% 0.966

Multiparametric MRI has excellent sensitivity for detecting aggressive PCa Gleason score 7 or higher


Commitment to evidence-based medicine

# Patients 19 14 61 61 16
# Any CaP 6 6 29 34 15
Gleason ≥ CaP 3 1 9 14 7

94% of men with image grade 5 on MRI had PCa

Accurate targeting of lesions identified on mpMRI using ultrasound fusion biopsy in clinic

Workflow

Eigen brings innovation to prostate biopsy & focal therapy

FDA, CE, TGA CMDCAS Certified

CONTACT US FOR MORE INFORMATION

Copyright 2017 © Vision Medical